{"Symbol": "AEMD", "AssetType": "Common Stock", "Name": "Aethlon Medical Inc", "Description": "Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life- and organ-threatening diseases in the United States. The company is headquartered in San Diego, California.", "CIK": "882291", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "MEDICAL DEVICES", "Address": "11555 SORRENTO VALLEY ROAD, SAN DIEGO, CA, UNITED STATES, 92121", "OfficialSite": "https://www.aethlonmedical.com", "FiscalYearEnd": "March", "LatestQuarter": "2025-12-31", "MarketCapitalization": "1907500", "EBITDA": "-6758249", "PERatio": "0.0094", "PEGRatio": "0", "BookValue": "25.48", "DividendPerShare": "None", "DividendYield": "None", "EPS": "209.2", "RevenuePerShareTTM": "0.236", "ProfitMargin": "0", "OperatingMarginTTM": "0", "ReturnOnAssetsTTM": "-0.548", "ReturnOnEquityTTM": "-1.914", "RevenueTTM": "574240", "GrossProfitTTM": "574240", "DilutedEPSTTM": "209.2", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "42.78", "AnalystTargetPrice": "9.75", "AnalystRatingStrongBuy": "0", "AnalystRatingBuy": "0", "AnalystRatingHold": "2", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "0.0094", "ForwardPE": "0.21", "PriceToSalesRatioTTM": "2.373", "PriceToBookRatio": "0.332", "EVToRevenue": "1.066", "EVToEBITDA": "0.244", "Beta": "1.603", "52WeekHigh": "53.27", "52WeekLow": "1.857", "50DayMovingAverage": "2.774", "200DayMovingAverage": "10.97", "SharesOutstanding": "973210", "SharesFloat": "756330", "PercentInsiders": "2.359", "PercentInstitutions": "3.694", "DividendDate": "2019-10-15", "ExDividendDate": "None"}